288 related articles for article (PubMed ID: 31898971)
1. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
3. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
Sun SC
Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
[TBL] [Abstract][Full Text] [Related]
4. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
Komander D; Lord CJ; Scheel H; Swift S; Hofmann K; Ashworth A; Barford D
Mol Cell; 2008 Feb; 29(4):451-64. PubMed ID: 18313383
[TBL] [Abstract][Full Text] [Related]
5. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
Elliott PR; Leske D; Hrdinka M; Bagola K; Fiil BK; McLaughlin SH; Wagstaff J; Volkmar N; Christianson JC; Kessler BM; Freund SM; Komander D; Gyrd-Hansen M
Mol Cell; 2016 Sep; 63(6):990-1005. PubMed ID: 27591049
[TBL] [Abstract][Full Text] [Related]
6. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
[TBL] [Abstract][Full Text] [Related]
7. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
[TBL] [Abstract][Full Text] [Related]
8. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
Kobayashi T; Masoumi KC; Massoumi R
Oncogene; 2015 Apr; 34(17):2251-60. PubMed ID: 24909169
[TBL] [Abstract][Full Text] [Related]
11. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinases in the regulation of NF-κB signaling.
Harhaj EW; Dixit VM
Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-kappaB survival signaling in hepatocellular carcinoma.
Chu L; Gu J; He Z; Xiao T; Liu X
Cancer Biol Ther; 2006 Jun; 5(6):615-22. PubMed ID: 16627981
[TBL] [Abstract][Full Text] [Related]
14. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum to "Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling" [Biochem. Biophys. Res. Commun. 524 (1) (2020) 1-7].
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2021 Jan; 536():115. PubMed ID: 33390248
[No Abstract] [Full Text] [Related]
16. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
Jin W; Reiley WR; Lee AJ; Wright A; Wu X; Zhang M; Sun SC
J Biol Chem; 2007 May; 282(21):15884-93. PubMed ID: 17392286
[TBL] [Abstract][Full Text] [Related]
18. Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.
Wright A; Reiley WW; Chang M; Jin W; Lee AJ; Zhang M; Sun SC
Dev Cell; 2007 Nov; 13(5):705-716. PubMed ID: 17981138
[TBL] [Abstract][Full Text] [Related]
19. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
Nagabhushana A; Bansal M; Swarup G
PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
